OEM/ODM China MFA - 2-n-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl)benzimidazole 152628-02-9 – Freemen
OEM/ODM China MFA - 2-n-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl)benzimidazole 152628-02-9 – Freemen Detail:
☑ It is used as an intermediate of the drug Telmisartan (T017000).
☑ More than 30 years production experience;
☑ Registered material under EU-REACH regulations;
☑ Product approved by multinationals in several industry;
☑ Just-in-time Delivery:1 week lead time.
☑ We have complete quality management system, not limited to sampling, method of analysis, sample retainment, Standard operation process;
☑ Freemen ensures the consisitency of quality, the strict process of management of changes is followed, including process and equipment, raw material supplies, packing;
☑ The sample could arrive in your hands within 20 days for international customers;
☑ The minimum order quantity is based on one package;
☑ We will feedback to your enquires within 24hours, Dedicated technical team will follow up and ready to give solutions if you have any request;
Welcome contact for more details!
Product detail pictures:
Related Product Guide:
We believe that prolonged time period partnership is really a result of top of the range, benefit added provider, prosperous knowledge and personal contact for OEM/ODM China MFA - 2-n-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl)benzimidazole 152628-02-9 – Freemen, The product will supply to all over the world, such as: Honduras, Liverpool, Israel, With the enterprising spirit of" high efficiency, convenience, practicality and innovation", and in line with such serving guidance of "good quality but better price, " and "global credit", we've been striving to cooperate with the automobile parts companies all over the world to make a win-win partnership.
By Aurora from Cannes - 2017.10.13 10:47
Good quality and fast delivery, it's very nice. Some products have a little bit problem, but the supplier replaced timely, overall, we are satisfied.
By Carey from Azerbaijan - 2018.06.21 17:11
